Essential biopharma news and analysis

Independent journalism since 2016

Full articles inside the email — read the news on your terms. Uncluttered design. Sharp writing. And it's absolutely free — or you can pay to get Endpoints News without the email advertising. Corporate subscriptions are one simple price, regardless of size. With Endpoints, you'll never miss an important drug development story again.

EARLY EDITION News and links by Arsalan Arif & Amber Tong Business days 7:15 AM ET (sample issue)

Endpoints News All the news by John Carroll & Team Business Days at 11:30 AM ET (sample issue)

Endpoints Pharma Pharma news and analysis Business days at 2 PM ET (sample issue)

Endpoints Marketing Rx Covers advertising and the drug commercialization world Tuesday at 2 PM ET (sample issue)

Endpoints FDA+ Regulatory news and analysis for drug developers Wednesday at 2PM ET (sample issue)

Endpoints Manufacturing Weekly biopharma manufacturing report Thursday at 2 PM ET (sample issue)

Endpoints Weekly Recaps the most important developments Saturday at 6 AM ET

Endpoints News is an independent journalism company. Readers fund our growth with premium subscriptions, ensuring our long-term viability. Advertising from trusted partners screened by Endpoints guarantees access for all to quality journalism. Here's our privacy policy.